Digital health executives predict that funding in 2024 will increase for companies with proven helpful platforms for healthcare providers and patients, while those not showing value will be forced to dissolve. Mergers and acquisitions will be prominent, and genAI companies may take center stage in garnering funding. The traditional digital health funding seen during and post-pandemic will be reduced, while genAI has the power to transform the industry, especially within clinical and drug discovery. Venture capital and private equity will prioritize companies with a proven product-market fit and clear path to profitability. Investors will likely be attracted to digital health startups that have demonstrated sustainable growth and a path to profitability.
Source link
Predictions for digital health funding in 2024
